157 related articles for article (PubMed ID: 11997807)
1. Functional results after treatment of retinoblastoma.
Desjardins L; Chefchaouni MC; Lumbroso L; Levy C; Asselain B; Bours D; Vedrenne J; Zucker JM; Doz F
J AAPOS; 2002 Apr; 6(2):108-11. PubMed ID: 11997807
[TBL] [Abstract][Full Text] [Related]
2. [Diode laser thermotherapy and chemothermotherapy in the treatment of retinoblastoma].
Lumbroso L; Doz F; Levy C; Dendale R; Vedrenne J; Bours D; Zucker JM; Asselain B; Desjardins L
J Fr Ophtalmol; 2003 Feb; 26(2):154-9. PubMed ID: 12660589
[TBL] [Abstract][Full Text] [Related]
3. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation.
Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG
Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578
[TBL] [Abstract][Full Text] [Related]
4. [Functional results of retinoblastoma treatment with local treatment used in isolation or associated with chemotherapy].
Desjardins L; Chefchaouni MC; Lumbroso L; Levy C; Asselain B; Bours D; Dendale R; Estève M; Michon J; Doz F
J Fr Ophtalmol; 2005 Sep; 28(7):725-31. PubMed ID: 16208222
[TBL] [Abstract][Full Text] [Related]
5. Eye-preserving therapy in retinoblastoma: prolonged primary chemotherapy alone or combined with local therapy.
Shin JY; Kim JH; Yu YS; Khwarg SI; Choung HK; Shin HY; Ahn HS
Korean J Ophthalmol; 2010 Aug; 24(4):219-24. PubMed ID: 20714385
[TBL] [Abstract][Full Text] [Related]
6. Chemothermotherapy in the management of retinoblastoma.
Lumbroso L; Doz F; Urbieta M; Levy C; Bours D; Asselain B; Vedrenne J; Zucker JM; Desjardins L
Ophthalmology; 2002 Jun; 109(6):1130-6. PubMed ID: 12045055
[TBL] [Abstract][Full Text] [Related]
7. Outcomes in retinoblastoma, 1974-2005: the Children's Hospital, Westmead.
Berman EL; Donaldson CE; Giblin M; Martin FJ
Clin Exp Ophthalmol; 2007; 35(1):5-12. PubMed ID: 17300564
[TBL] [Abstract][Full Text] [Related]
8. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Singh A; Friedman DL; Naduvilath TJ
Am J Ophthalmol; 2002 May; 133(5):657-64. PubMed ID: 11992863
[TBL] [Abstract][Full Text] [Related]
9. Combined chemotherapy and local treatment in the management of intraocular retinoblastoma.
Brichard B; De Bruycker JJ; De Potter P; Neven B; Vermylen C; Cornu G
Med Pediatr Oncol; 2002 Jun; 38(6):411-5. PubMed ID: 11984802
[TBL] [Abstract][Full Text] [Related]
10. Conservative treatments of intraocular retinoblastoma.
Lumbroso-Le Rouic L; Aerts I; Lévy-Gabriel C; Dendale R; Sastre X; Esteve M; Asselain B; Bours D; Doz F; Desjardins L
Ophthalmology; 2008 Aug; 115(8):1405-10, 1410.e1-2. PubMed ID: 18222001
[TBL] [Abstract][Full Text] [Related]
11. Factors predictive of long-term visual outcomes of Group D eyes treated with chemoreduction and low-dose IMRT salvage: the Children's Hospital Los Angeles experience.
Berry JL; Jubran R; Wong K; Lee TC; Murphree AL; Kim JW
Br J Ophthalmol; 2014 Aug; 98(8):1061-5. PubMed ID: 24671926
[TBL] [Abstract][Full Text] [Related]
12. Vitreoretinal complications of retinoblastoma treatment.
Tawansy KA; Samuel MA; Shammas M; Murphree AL
Retina; 2006 Sep; 26(7 Suppl):S47-52. PubMed ID: 16946679
[TBL] [Abstract][Full Text] [Related]
13. Ocular and orbital complications following the treatment of retinoblastoma.
Anteby I; Ramu N; Gradstein L; Miskin H; Pe'er J; Benezra D
Eur J Ophthalmol; 1998; 8(2):106-11. PubMed ID: 9673480
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of neonatal retinoblastoma in pre-chemotherapy and chemotherapy eras.
Camp DA; Dalvin LA; Schwendeman R; Lim LS; Shields CL
Indian J Ophthalmol; 2019 Dec; 67(12):1997-2004. PubMed ID: 31755437
[TBL] [Abstract][Full Text] [Related]
15. A prospective study of children treated for retinoblastoma: cognitive and visual outcomes in relation to treatment.
Ek U; Seregard S; Jacobson L; Oskar K; Af Trampe E; Kock E
Acta Ophthalmol Scand; 2002 Jun; 80(3):294-9. PubMed ID: 12059869
[TBL] [Abstract][Full Text] [Related]
16. Chemoreduction for unilateral retinoblastoma.
Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Naduvilath TJ
Arch Ophthalmol; 2002 Dec; 120(12):1653-8. PubMed ID: 12470138
[TBL] [Abstract][Full Text] [Related]
17. Vitreous relapse following primary chemotherapy for retinoblastoma: is adjuvant diode laser a risk factor?
Gombos DS; Cauchi PA; Hungerford JL; Addison P; Coen PG; Kingston JE
Br J Ophthalmol; 2006 Sep; 90(9):1168-72. PubMed ID: 16707528
[TBL] [Abstract][Full Text] [Related]
18. Plaque radiotherapy for retinoblastoma: long-term tumor control and treatment complications in 208 tumors.
Shields CL; Shields JA; Cater J; Othmane I; Singh AD; Micaily B
Ophthalmology; 2001 Nov; 108(11):2116-21. PubMed ID: 11713089
[TBL] [Abstract][Full Text] [Related]
19. Retinoblastoma in Victoria, 1976-2000: changing management trends and outcomes.
Dondey JC; Staffieri S; McKenzie J; Davie G; Elder J
Clin Exp Ophthalmol; 2004 Aug; 32(4):354-9. PubMed ID: 15281966
[TBL] [Abstract][Full Text] [Related]
20. Globe conserving treatment of the only eye in bilateral retinoblastoma.
Lee V; Hungerford JL; Bunce C; Ahmed F; Kingston JE; Plowman PN
Br J Ophthalmol; 2003 Nov; 87(11):1374-80. PubMed ID: 14609838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
